188 related articles for article (PubMed ID: 20885081)
1. Amyloid imaging using high-field magnetic resonance.
Amatsubo T; Yanagisawa D; Morikawa S; Taguchi H; Tooyama I
Magn Reson Med Sci; 2010; 9(3):95-9. PubMed ID: 20885081
[TBL] [Abstract][Full Text] [Related]
2. Amyloid imaging using fluorine-19 magnetic resonance imaging ((19)F-MRI).
Tooyama I; Yanagisawa D; Taguchi H; Kato T; Hirao K; Shirai N; Sogabe T; Ibrahim NF; Inubushi T; Morikawa S
Ageing Res Rev; 2016 Sep; 30():85-94. PubMed ID: 26772439
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
[TBL] [Abstract][Full Text] [Related]
4. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
5. [Amyloid-plaque imaging of the brain using PET].
Ossenkoppele R; Tolboom N; Pijnenburg YA; Lammertsma AA; Scheltens P; van Berckel BN
Ned Tijdschr Geneeskd; 2011; 155():A2981. PubMed ID: 21586182
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
Matharu B; Spencer N; Howe F; Austen B
Neuropeptides; 2015 Oct; 53():63-70. PubMed ID: 26234669
[TBL] [Abstract][Full Text] [Related]
7. Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
Sulheim E; WiderØe M; Bäck M; Nilsson KPR; Hammarström P; Nilsson LNG; Davies CL; Åslund AKO
J Alzheimers Dis; 2023; 93(2):411-419. PubMed ID: 37038807
[TBL] [Abstract][Full Text] [Related]
8. Fluorine-18 radiolabeled heterocycles as PET tracers for imaging β-amyloid plaques in Alzheimer's disease.
Zeng F; Goodman MM
Curr Top Med Chem; 2013; 13(8):909-19. PubMed ID: 23590167
[TBL] [Abstract][Full Text] [Related]
9. Technology Insight: imaging amyloid plaques in the living brain with positron emission tomography and MRI.
Huddleston DE; Small SA
Nat Clin Pract Neurol; 2005 Dec; 1(2):96-105. PubMed ID: 16932505
[TBL] [Abstract][Full Text] [Related]
10. Visualizing pathology deposits in the living brain of patients with Alzheimer's disease.
Kepe V; Huang SC; Small GW; Satyamurthy N; Barrio JR
Methods Enzymol; 2006; 412():144-60. PubMed ID: 17046657
[TBL] [Abstract][Full Text] [Related]
11. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
12. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
13. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
14. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
[TBL] [Abstract][Full Text] [Related]
15. Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Li J; Wang J; Hoang DM; Sun Y; Xu H; Tsui W; Li Y; Boutajangout A; Wang A; de Leon M; Wisniewski T
PLoS One; 2013; 8(2):e57097. PubMed ID: 23468919
[TBL] [Abstract][Full Text] [Related]
16. A Novel Magnetic Nanoparticle for Early Detection of Amyloid Plaques in Alzheimer's Disease.
Zeng J; Wu J; Li M; Wang P
Arch Med Res; 2018 May; 49(4):282-285. PubMed ID: 30266531
[TBL] [Abstract][Full Text] [Related]
17. A novel 18F-labeled pyridyl benzofuran derivative for imaging of β-amyloid plaques in Alzheimer's brains.
Cheng Y; Ono M; Kimura H; Kagawa S; Nishii R; Saji H
Bioorg Med Chem Lett; 2010 Oct; 20(20):6141-4. PubMed ID: 20817524
[TBL] [Abstract][Full Text] [Related]
18. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates.
Lee D; Kim SM; Kim HY; Kim Y
ACS Chem Neurosci; 2019 Jun; 10(6):2647-2657. PubMed ID: 31009195
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
